meta-Hydroxynorephedrine
meta-Hydroxynorephedrine or 3-hydroxynorephedrine, also known as 3,β-dihydroxyamphetamine, is an adrenergic drug of the amphetamine class which was patented as a vasopressor and nasal decongestant but was never marketed.[1][2] It is the racemic form of the sympathomimetic drug metaraminol.
Clinical data | |
---|---|
Other names | m-hydroxypropadrine m-hydroxyphenylpropanolamine α-methyl-m-octopamine 3,β-dihydroxyamphetamine 3,β-dihydroxy-α-methylphenethylamine |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C9H13NO2 |
Molar mass | 167.208 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
See also
- Hydroxynorephedrine
- Metaraminol
- Gepefrine
- Phenylpropanolamine
References
- Macdonald F (1997). Dictionary of Pharmacological Agents. CRC Press. p. 106. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.
- Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. 15 January 2013. p. 2110. ISBN 978-0-8155-1526-5. Retrieved 24 April 2012.
Cardiac stimulants excluding cardiac glycosides (C01C) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adrenergic and dopaminergic agents |
| ||||||||||||||
Phosphodiesterase inhibitors (PDE3I) | |||||||||||||||
Other cardiac stimulants | |||||||||||||||
|
Decongestants and other nasal preparations (R01) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Topical |
| ||||||||||
Systemic use: Sympathomimetics | |||||||||||
|
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.